Opioid overdose fatality prevention

JAMA

Volumn 309, Issue 9, 2013, Pages 873-874

  Leece, Pamela ^a   Orkin, Aaron ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

NALOXONE; OPIATE; NARCOTIC ANALGESIC AGENT; NARCOTIC ANTAGONIST;

DRUG FATALITY; DRUG OVERDOSE; EMERGENCY HEALTH SERVICE; HEALTH PROGRAM; HUMAN; LETTER; MEDICAL INFORMATION; MEDICAL RESEARCH; MORBIDITY; MORTALITY; PRIORITY JOURNAL; DRUG MISUSE; NOTE;

ANALGESICS, OPIOID; HUMANS; NALOXONE; NARCOTIC ANTAGONISTS; PRESCRIPTION DRUG MISUSE;

EID: 84874677868     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2013.375     Document Type: Letter

References (5)

1. Beletsky L, Rich JD, Walley AY. Prevention of fatal opioid overdose. JAMA. 2012;308(18):1863-1864.
2. Gaston RL, Best D, Manning V, Day E. Can we prevent drug related deaths by training opioid users to recognise and manage overdoses? Harm Reduct J. 2009;6:26.
3. Strang J, Manning V, Mayet S, et al. Overdose training and take-home naloxone for opiate users: prospective cohort study of impact on knowledge and attitudes and subsequent management of overdoses. Addiction. 2008;103(10):1648-1657.
4. Tobin KE, Sherman SG, Beilenson P, Welsh C, Latkin CA. Evaluation of the Staying Alive programme: training injection drug users to properly administer naloxone and save lives. Int J Drug Policy. 2009;20(2):131-136.
5. Advisory Council on the Misuse of Drugs. Consideration of naloxone. http://www.homeoffice.gov.uk/publications/agencies-public-bodies/acmd1/ consideration-of-naloxone?view=Binary. Accessed November 22, 2012.